Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Perris

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Frontiers in Psychiatry|July 3, 2019
Comorbidity of Obsessive-Compulsive Disorder and Schizotypal Personality Disorder: Clinical Response and Treatment Resistance to Pharmacotherapy in a 3-Year Follow-Up Naturalistic StudyFrancesco Perris, Michele Fabrazzo, Valeria De Santis, et al.
Psychiatry Research|June 27, 2017
Clozapine versus other antipsychotics during the first 18 weeks of treatment: A retrospective study on risk factor increase of blood dyscrasiasMichele Fabrazzo, Vincenzo Prisco, Gaia Sampogna, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 18, 2009
Obsessive-compulsive disorder with poor insight: a three-year prospective studyFrancesco Catapano, Francesco Perris, Michele Fabrazzo, et al.
Rivista Di Psichiatria|July 1, 2016
[Drug safety warnings in psychiatry: adverse drug reactions' signaling from 2002 to 2014]Vincenzo Prisco, Teresa Iannaccone, Adriano Tusciano, et al.
Clinics and Practice|March 26, 2025
Two Long-Acting Antipsychotics in a Patient with Treatment-Resistant Schizophrenia: A Case ReportSalvatore Cipolla, Flora Delli Carpini, Pierluigi Catapano, et al.
Rivista Di Psichiatria|December 22, 2020
[The revision process of diagnostic systems in psychiatry: differences between ICD-11 and DSM-5]Gaia Sampogna, Valeria Del Vecchio, Vincenzo Giallonardo, et al.
Psychiatry Research|March 26, 2021
Duration of untreated illness predicts 3-year outcome in patients with obsessive-compulsive disorder: A real-world, naturalistic, follow-up studyFrancesco Perris, Gaia Sampogna, Vincenzo Giallonardo, et al.
Journal of Personalized Medicine|December 29, 2022
The Psychiatric Consequences of Long-COVID: A Scoping ReviewGaia Sampogna, Matteo Di Vincenzo, Vincenzo Giallonardo, et al.
Neuropsychobiology|September 5, 2015
Olanzapine Is Faster than Haloperidol in Inducing Metabolic Abnormalities in Schizophrenic and Bipolar PatientsMichele Fabrazzo, Palmiero Monteleone, Vincenzo Prisco, et al.
Medicina (Kaunas, Lithuania)|November 27, 2021
Delirium and Cognitive Impairment as Predisposing Factors of COVID-19 Infection in Neuropsychiatric Patients: A Narrative ReviewMichele Fabrazzo, Antonio Russo, Alessio Camerlengo, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Frontiers in Psychiatry|July 3, 2019
Comorbidity of Obsessive-Compulsive Disorder and Schizotypal Personality Disorder: Clinical Response and Treatment Resistance to Pharmacotherapy in a 3-Year Follow-Up Naturalistic StudyFrancesco Perris, Michele Fabrazzo, Valeria De Santis, et al.
Psychiatry Research|June 27, 2017
Clozapine versus other antipsychotics during the first 18 weeks of treatment: A retrospective study on risk factor increase of blood dyscrasiasMichele Fabrazzo, Vincenzo Prisco, Gaia Sampogna, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 18, 2009
Obsessive-compulsive disorder with poor insight: a three-year prospective studyFrancesco Catapano, Francesco Perris, Michele Fabrazzo, et al.
Rivista Di Psichiatria|July 1, 2016
[Drug safety warnings in psychiatry: adverse drug reactions' signaling from 2002 to 2014]Vincenzo Prisco, Teresa Iannaccone, Adriano Tusciano, et al.
Clinics and Practice|March 26, 2025
Two Long-Acting Antipsychotics in a Patient with Treatment-Resistant Schizophrenia: A Case ReportSalvatore Cipolla, Flora Delli Carpini, Pierluigi Catapano, et al.
Rivista Di Psichiatria|December 22, 2020
[The revision process of diagnostic systems in psychiatry: differences between ICD-11 and DSM-5]Gaia Sampogna, Valeria Del Vecchio, Vincenzo Giallonardo, et al.
Psychiatry Research|March 26, 2021
Duration of untreated illness predicts 3-year outcome in patients with obsessive-compulsive disorder: A real-world, naturalistic, follow-up studyFrancesco Perris, Gaia Sampogna, Vincenzo Giallonardo, et al.
Journal of Personalized Medicine|December 29, 2022
The Psychiatric Consequences of Long-COVID: A Scoping ReviewGaia Sampogna, Matteo Di Vincenzo, Vincenzo Giallonardo, et al.
Neuropsychobiology|September 5, 2015
Olanzapine Is Faster than Haloperidol in Inducing Metabolic Abnormalities in Schizophrenic and Bipolar PatientsMichele Fabrazzo, Palmiero Monteleone, Vincenzo Prisco, et al.
Medicina (Kaunas, Lithuania)|November 27, 2021
Delirium and Cognitive Impairment as Predisposing Factors of COVID-19 Infection in Neuropsychiatric Patients: A Narrative ReviewMichele Fabrazzo, Antonio Russo, Alessio Camerlengo, et al.
Pageof 4